Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06482164 · ClinicalTrials.gov registry record · NA
The THINK Study Incidence of Neurotrophic Keratopathy)
A NA study of Dry Eye, sponsored by Research Insight.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06482164: Recruiting NA study of Dry Eye, sponsored by Research Insight.
NCT06482164 is a NA study of Dry Eye that is actively recruiting participants, run by Research Insight. The registered enrollment target is 60 participants, below the 94-participant average among 41 other Dry Eye trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06482164, a NA study of Dry Eye, is actively recruiting participants, sponsored by Research Insight.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The study purpose is to evaluate corneal sensitivity in patients that have Stage 1 Neurotrphic Keratopathy (NK). Identifying patients with Stage 1 NK, may predict those who will in the future require rhNGF for optimal visual performance.
Primary Outcome
Patients with stage 1 neurotrophic keratopathy NK among dry eye patients
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Dry Eye Disease
Study Locations (1)
California
- Harvard Eye Associates - Laguna Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-04-05 |
| Est. Completion | 2025-04-01 |
| Phase | NA |
What NCT06482164 shows while recruiting
NCT06482164 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 94-participant average among 41 other Dry Eye trials with a reported enrollment target (36% lower).
The record links to 1 condition, with Dry Eye appearing as the primary indexed condition, and to 1 intervention - of which Dry Eye Disease is the first listed.
NCT06482164 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06482164 about?
NCT06482164 is a clinical study titled "The THINK Study Incidence of Neurotrophic Keratopathy)". The study purpose is to evaluate corneal sensitivity in patients that have Stage 1 Neurotrphic Keratopathy (NK). Identifying patients with Stage 1 NK, may predict those who will in the future require rhNGF for optimal visual performance.
What is the current status of trial NCT06482164?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-04-05. Estimated completion is 2025-04-01.
What conditions does trial NCT06482164 study?
This clinical trial studies the following conditions: Dry Eye.
What interventions are being tested in trial NCT06482164?
The interventions under investigation include: Dry Eye Disease (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06482164?
This trial is sponsored by Research Insight, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06482164 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dry Eye
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06482164's enrollment target sits among peer trials
60 16th of 41 higher than 23 of 41 other Dry Eye trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dry Eye trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Low Level Light Therapy & Skin Pigmentation
RECRUITING · NA
-
Corneal Epithelial Stem Cells and Dry Eye Disease
COMPLETED · NA
-
Acute Comfort of Lubricant Eye Drops FID 112903
COMPLETED · NA
-
Evaluation of Extended Tear Film Break Up Time (TFBUT) With an Ocular Emulsion
COMPLETED · NA
-
Efficacy of IPL Treatment of Dry Eye and Ocular Rosacea
COMPLETED · NA
-
Intense Pulse Light Treatment With Meibomian Gland Expression of the Upper Eyelids in Dry Eye Disease
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI